SCHEMBL224329

SCHEMBL224329

[c]1cc2c3c(c1)CCCN3CCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.47
RAD52 P43351 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
HTR2C P28335 4/20 0.43
HTR2B P41595 2/20 0.38
MEN1 O00255 3/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 3/20 0.37
RECQL P46063 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
USP2 O75604 2/20 0.37
GAA P10253 2/20 0.37
POLB P06746 2/20 0.37
HPGD P15428 2/20 0.37
BLM P54132 2/20 0.37
PABPC1 P11940 1/20 0.37
ALOX15 P16050 1/20 0.37
NR4A1 P22736 1/20 0.37
APEX1 P27695 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3354534 0.96 KMT2A (0.44) KMT2ARAD52RXFP1HTR2CHTR2B
SCHEMBL60540 0.73 HTR2C (0.69) KMT2ARAD52RXFP1HTR2CHTR2B
SCHEMBL11223239 0.73 KMT2A (0.59) KMT2ARAD52RXFP1HTR2CHTR2B
SCHEMBL13989159 0.73 KMT2A (0.53) KMT2ARAD52RXFP1HTR2CHTR2B
Bromide SCHEMBL8863742 0.71 HTR2C (0.67) KMT2ARAD52RXFP1HTR2CHTR2B
SCHEMBL2837125 0.71 KMT2A (0.47) KMT2ARAD52RXFP1HTR2CHTR2B
SCHEMBL6990481 0.71 CYP11B1 (0.48) KMT2AL3MBTL1
SCHEMBL6996752 0.70 KMT2A (0.40) KMT2ARAD52RXFP1HTR2CHTR2B
SCHEMBL6992548 0.70 NPC1 (0.50) KMT2AMAPTTDP1GAALMNA
SCHEMBL15267534 0.70 KMT2A (0.50) KMT2ARAD52RXFP1HTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 705 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3268375-B1 PHOTOCHROMIC THIENOCHROMENE COMPOUNDS TRANSITIONS OPTICAL INC (US) 2022-06-15 EP claimed
US-20220137262-A1 OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS WITH REACTIVE SUBSTITUENTS JOHNSON & JOHNSON VISION CARE (US) 2022-05-05 US claimed
EP-3071576-B9 PHOTOCHROMIC INDENO-FUSED RING PYRAN COMPOUNDS TRANSITIONS OPTICAL INC (US) 2021-12-22 EP claimed
EP-3645540-B1 SILOLE AND GERMOLE FUSED RING PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL LTD (IE) 2021-11-03 EP claimed
EP-3071576-B1 PHOTOCHROMIC INDENO-FUSED RING PYRAN COMPOUNDS TRANSITIONS OPTICAL INC (US) 2021-08-18 EP claimed
CN-105199708-B Photochromic compounds 光学转变公司 2020-10-27 CN claimed
US-20200172798-A1 Silole and Germole Fused Ring Photochromic Compounds TRANSITIONS OPTICAL, LTD. (IE) 2020-06-04 US claimed
EP-3645540-A1 SILOLE AND GERMOLE FUSED RING PHOTOCHROMIC COMPOUNDS Transitions Optical, Ltd. (IE) 2020-05-06 EP claimed
EP-3621958-A1 PHOTOCHROMIC INDENO FUSED PHENANTHRENOPYRAN COMPOUNDS Transitions Optical, Ltd. (IE) 2020-03-18 EP claimed
CN-110799514-A Silole and germacyclopentadiene fused ring photochromic compounds 光学转变有限公司 2020-02-14 CN claimed
US-4365016-A ELECTROGRAPHY EASTMAN KODAK COMPANY (US) 1982-12-21 US claimed
US-4365017-A ELECTROGRAPHY EASTMAN KODAK COMPANY (US) 1982-12-21 US claimed
US-4363503-A FOR PRESSURE SENSITIVE CARBONLESS DUPLICATING AND THERMAL MARKING SYSTEMS STERLING DRUG INC. (US) 1982-12-14 US claimed
EP-0061128-A1 Pyridine compounds, process for their preparation and systems containing them STERLING DRUG INC. (US) 1982-09-29 EP claimed
US-4255577-A Process and intermediates for preparing 3-[4-(disubstituted-amino)phenyl] or STERLING DRUG INC. (US) 1981-03-10 US claimed
US-4200313-A Carbonless duplicating systems STERLING DRUG INC. (US) 1980-04-29 US claimed
US-4175956-A Electrophotosensitive materials for migration imaging processes EASTMAN KODAK COMPANY (US) 1979-11-27 US claimed
US-4168378-A THERMOGRAPHY, LEUCO DYES STERLING DRUG INC. (US) 1979-09-18 US claimed
US-4146707-A PHOTOELECTROPHORESIS EASTMAN KODAK COMPANY (US) 1979-03-27 US claimed
US-4119776-A Vinyl phthalide color formers NCR CORPORATION (US) 1978-10-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172798-A1 Silole and Germole Fused Ring Photochromic Compounds CCNB2, SKP2, CCNB1 KMT2A 888/4885RAD52 640/4885RXFP1 3743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.